07.08.25 -- The Latest Techniques And Technology For Differentiating Capsids

Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells.

Explore four common applications of cryopreservation and the science behind selecting the appropriate materials to build single-use solutions that enable cryogenic storage for cell and gene applications.

Compare in-house buffer preparation to outsourcing buffer preparation activities, highlighting the potential for optimizing resources and mitigating risks.

CAR-T cell therapy is evolving rapidly, with scientists exploring new ways to improve efficacy, safety, and applicability. Precision media formulation plays a key role in optimizing therapeutic cell quality.

Storage of a vial containment system at ultra-low temperature presents risk not encountered at ambient temperature. Review material advantages of cyclic olefin polymer vials.

Discover how Germfree tackled a unique challenge from the Public Health Agency of Canada by designing a custom Class III biosafety cabinet for advanced virology studies and disease surveillance.

The transition from manual to automated cell processing is vital for therapeutic success. A versatile, single-use system reduces variability and ensures product quality throughout manufacturing.

Achieving high-quality viral vectors demands rigorous control over contaminants. Learn about enzymatic approaches to significantly reduce nucleic acid impurities in your manufacturing processes.

In the evolving world of biopharmaceutical manufacturing, explore how single-use filtration remains a vital yet overlooked process essential to ensuring product purity and patient safety.